Vaxcyte: Pay

Vaxcyte paid its one named executive on file $5.8M in FY2025 (Dec).

Pay$100 in the stock at the end of FY20 → $235
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Grant E. PickeringChief Executive Officer
FY2024 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
3 years
Andrew Guggenhime, M.B.A.President and Chief Financial Officer
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Jim WassilExecutive Vice President and Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Mikhail EydelmanSenior Vice President, General Counsel and Corporate Secretary
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
3 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 6 peers with pay on file was $12.7M. CEO pay of Vaxcyte for that year is not on file.

  1. 1CRISPR Therapeutics AG
  2. 2BridgeBio Pharma
  3. 3Cytokinetics
  4. 4INSMED
  5. 5Revolution Medicines
  6. 6Acadia Pharmaceuticals
  7. 7VaxcyteNot disclosed
  8. 8Apellis Pharmaceuticals, Inc.Not disclosed
  9. 9Arcus Biosciences, Inc.Not disclosed
  10. 10Arrowhead Pharmaceuticals, Inc.Not disclosed
  11. 11Cerevel Therapeutics Holdings, Inc.Not disclosed
  12. 12Corcept TherapeuticsNot disclosed
  13. 13Denali Therapeutics Inc.Not disclosed
  14. 14ExelixisNot disclosed
  15. 15Immunovant, Inc.Not disclosed
  16. 16Intellia Therapeutics, Inc.Not disclosed
  17. 17Intra-Cellular Therapies, Inc.Not disclosed
  18. 18Karuna Therapeutics, Inc.Not disclosed
  19. 19Mirati Therapeutics, Inc.Not disclosed
  20. 20Prothena Corporation plcNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.